Borane → HCID 59464071, compound
Reaction equation
B.[F:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[NH:9][C:10]1[O:14][C:13]([C:15]([NH:17][C:18]2[CH:23]=[CH:22][C:21]([CH:24]3[CH2:29][CH2:28][CH:27]([CH2:30][C:31](O)=[O:32])[CH2:26][CH2:25]3)=[CH:20][CH:19]=2)=[O:16])=[N:12][N:11]=1>C1COCC1>[F:2][C:3]1[CH:8]=[CH:7][CH:6]=[CH:5][C:4]=1[NH:9][C:10]1[O:14][C:13]([C:15]([NH:17][C:18]2[CH:19]=[CH:20][C:21]([CH:24]3[CH2:29][CH2:28][CH:27]([CH2:30][CH2:31][OH:32])[CH2:26][CH2:25]3)=[CH:22][CH:23]=2)=[O:16])=[N:12][N:11]=1Participants
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
Borane (1 mL of a 1M solution in THF) was added to a stirred solution of (4-{4-[({5-[(2-fluorophenyl)amino]-1,3,4-oxadiazol-2-yl}carbonyl)amino]phenyl}cyclohexyl)acetic acid (Intermediate 45, 79 mg) in THF (2 mL). The reaction mixture was stirred for 16 hours. The mixture was evaporated and the residue dissolved in DCM (10 mL) then washed with brine (10 mL), dried and concentrated in vacuo to give a solid. This solid was purified by HPLC eluting with a gradient of acetonitrile/water containing 0.2% TFA to give the title compound (35 mg) as a solid, a ca. 2:1 trans:cis isomeric mixture; 1H NMR δ 10.90 (1H, s), 10.72 (1H, s), 8.01 (1H, t), 7.65 (2H, m), 7.33-7.12 (5H, m), 4.28 (1H, m), 3.46 (2H, bs), 2.58-2.40 (1H+ DMSO, m), 1.80 (3H, bs), 1.68-1.50 (4H, m), 1.49-1.31 (3H, m), 1.05 (1H, m); MS m/e MH+ 425.
Workup
- customThe mixture was evaporated
- dissolutionthe residue dissolved in DCM (10 mL)
- washthen washed with brine (10 mL)
- customdried
- concentrationconcentrated in vacuo
- customto give a solid
- customThis solid was purified by HPLC
- washeluting with a gradient of acetonitrile/water containing 0.2% TFA
Sources & evidence
- ORD record
- ord-2c754996e0b842ba902b037c6439fb18
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07795283B2
Reaction notes
Loading…